Prospect:informationfortheuser
Duloxetina Alter30mgcapsulesustained-releasegastrorresistentesEFG
Leafletobjectoftheprospectbeforeuseandincaseofadverseevent,orifyouarealreadyundermedication,pleaseconsultyourdoctorbeforeusebecauseitmayinteractwithothermedicinesyouarecurrentlytakingormaycausesideeffectsorallergicreactions.
-Consulttheprospectandfollowtheinstructionscarefullybeforeuse.
-Storeinacool,dryplaceawayfromchildrenandanimalsoutofreachofchildrenandanimalsandawayfrommoistureandheatsourcesandawayfromdirectsunlightanddonotfreeze.
-Thismedicineisonlyforthepatientforwhomitwasprescribedandshouldnotbegiventootherpeopleeveniftheyhavesimilarsymptomsorthesamediagnosisasyoubecauseitmaycauseharmtothemorinteractwithothermedicinestheyarecurrentlytakingormaycausesideeffectsorallergicreactionsinthemoryoumaybepregnantorbreastfeedingoryoumayhaveotherhealthproblemsorallergiesorintolerancesoryoumaybetakingothermedicinesorsupplementsoryoumaybeundergoingothertreatmentsorproceduresoryoumayhaveotherquestionsorconcernsabouttheuseofthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsaboutthepriceoravailabilityofthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsaboutthequalityorsafetyofthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheenvironmentalimpactofthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheregulatorystatusofthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheavailabilityofinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofsocialmediaorotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofartificialintelligenceormachinelearningtoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofblockchaintechnologytoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitalplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofothertechnologiesorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealthcareoryoumayhavequestionsorconcernsabouttheuseofotherdigitaltoolsorplatformstoaccessinformationaboutthismedicineoranyotheraspectofyourhealth1. What is Duloxetina Alter and what is it used for Duloxetine Altercontieneelprincipioactivoduloxetina.Duloxetineaumentalosnivelesdeserotoninaynoradrenalinaenelsistemanervioso. Duloxetineempleaenadultosparatratar: Duloxetinecomenzaaactuarenlamayoríadepersonascondepresióno ansiedadalasdossemanas trashabercomenzadoeltratamiento,peropuedenpasarentre2 y 4semanashastaquecomiencea sentirsemejor.Ifyoudonotimproveafter2to4weeks,yourdoctormayincreaseyourdoseorswitchyoutoadifferentmedicationforyourconditionorpainsymptomsthataresevereorpersistent). In people with diabetic neuropathic pain, duloxetine may help you feel better after a few weeks. If you do not feel better after a few weeks, your doctor may increase your dose or switch you to a different medication for your condition or pain symptoms that are severe or persistent. Some people with diabetic neuropathic pain may feel better after a few weeks. If you do not feel better after a few weeks, your doctor may increase your dose or switch you to a different medication for your condition or pain symptoms that are severe or persistent.
Do not take Duloxetina Alter:
(listed in section6)
Consult your doctor if you have high blood pressure or heart disease. Your doctor will tell you if you should take duloxetine.
Warnings and precautions
Duloxetine may not be suitable for you for the following reasons.
Some medicines in the group to which Duloxetina Alter belongs (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
Consult your doctor before starting to take this medicine if:
Duloxetine may cause a feeling of restlessness or inability to sit still. If this happens, tell your doctor.
Thoughts of suicide and worsening of your depression or anxiety
If you are depressed and/or have anxiety disorders, you may occasionally have thoughts of self-harm or suicide. These thoughts may be increased at the beginning of treatment with antidepressants, as all these medicines take time to work, usually two weeks but sometimes longer.
It is more likely that you will have these thoughts if:
Contact your doctor or go directly to the hospital as soon as you have any thoughts of self-harm or suicide.
It may be helpful to tell a close friend or family member that you are depressed or have an anxiety disorder, and ask them to read this leaflet. They may be able to tell if your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.
You should also contact your doctor:
if you experience signs and symptoms of restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhoea, coma, nausea, vomiting, as you may be suffering from a serotonin syndrome.
In its most severe form, serotonin syndrome may resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by blood test).
Children and adolescents
Duloxetine should not normally be used in children and adolescents under 18 years old. Also, you should know that patients under 18 years old who take this class of medicines have an increased risk of side effects such as suicidal thoughts, suicidal behaviour and hostility (mainly aggression, oppositional behaviour and irritability). Despite this, your doctor may prescribe duloxetine to patients under 18 years old because they decide it may be beneficial for the patient. If your doctor has prescribed duloxetine to a patient under 18 years old and you want to talk about it, please go back to your doctor. You should tell your doctor if any of the symptoms mentioned above appear or get worse in patients under 18 years old who are taking duloxetine. Also, in this age group, the long-term safety effects of duloxetine related to growth, maturation and development of cognitive and behavioural functions have not yet been demonstrated.
Use of Duloxetina Alter with other medicines
Inform your doctor or pharmacist if you are using, have used recently or may have to take any other medicine, including those bought without a prescription.
The main component of Duloxetina Alter, duloxetine, is used in other medicines for other treatments:
You should avoid using more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetine.
Your doctor will decide if you can take duloxetine with other medicines.Do not start or stop taking any medicine, including those bought without a prescription and herbal remedies, without first consulting your doctor.
You should also tell your doctor if you are taking any of the following medicines:
MAOIs:do not take duloxetine if you are taking, or have taken in the last 14 days, another antidepressant known as a monoamine oxidase inhibitor (MAOI). Examples of MAOIs include moclobemide (an antidepressant) and linezolid (an antibiotic). Taking an MAOI with many prescription medicines, including duloxetine, can cause serious side effects, even life-threatening. You should wait at least 14 days after stopping treatment with an MAOI before taking duloxetine. Similarly, you should wait at least 5 days after stopping treatment with duloxetine before starting treatment with an MAOI.
Medicines that cause drowsiness:This includes prescription medicines prescribed by your doctor, such as benzodiazepines, powerful analgesics, antipsychotics, phenobarbital and antihistamines.
Medicines that increase serotonin levels:Triptans, tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine), tricyclic antidepressants (such as clomipramine, amitriptyline), petidina, St. John's Wort and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of side effects; if you notice any unusual symptoms when using any of these medicines with duloxetine, tell your doctor.
Oral anticoagulants or antiplatelet agents:Medicines that thin the blood or prevent the formation of blood clots. These medicines may increase the risk of bleeding.
Taking Duloxetina Alter with food, drinks and alcohol
Duloxetine can be taken with or without food. You should be careful if you take alcohol while taking duloxetine.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine.
Make sure your midwife and/or doctor know that you are taking duloxetine. Other similar medicines (SSRIs), taken during pregnancy, may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe more rapidly and turn blue. These symptoms usually start within the first 24 hours after the baby's birth. If this happens to your baby, you should contact your midwife and/or doctor immediately.
If you take duloxetine towards the end of your pregnancy, your baby may have some symptoms when it is born. These usually start at birth or within the first few days after the baby's birth. These symptoms may include weak muscles, trembling, nervousness, the baby not feeding properly, breathing problems and convulsions. If your baby has any of these symptoms when it is born or if you are concerned about your baby's health, contact your doctor or midwife, who can advise you.
Driving and operating machinery
During treatment with duloxetine, you may feel drowsy or dizzy. Do not drive or operate tools or machinery until you know how duloxetine affects you.
Duloxetina Alter contains saccharose
Duloxetine containssaccharose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Ifyoutaketoomuchduloxetina,consultyourdoctororpharmacistimmediately.Incaseofdoubt,consultyourdoctororpharmacistagain.
Duloxetinaisavailablebyoralroute.Takethecapsulewithaglassofwater.
Paralosquehanprescritoduloxetina,ladosisrecomendadaes60mgperday,perosumédicoleprescribiráladosismásapropiadaparausted.
Paralosquehanprescritoduloxetina,ladosisnodebeserreducidainicialmentea30mgperday,yluegoseincrementaráa60mgperday,perosumédicoleprescribiráladosismásapropiadaparausted.Sinosesigueeltratamiento,nosedebetomarduloxetinahasta12hoursafterthelastdoseofduloxetinathatday.
Toremembertotakeduloxetina,itmaybehelpfultotakeitatthesametimeeveryday.
Informyourdoctorifyoumissadoseofduloxetinaorifyoutaketoomuchduloxetinaatonetimeorifyoustoptakingduloxetinawithoutconsultingyourdoctorfirst.Itisimportanttofollowtheinstructionsgivenbyyourdoctortogetthebestresultsfromduloxetina.
Ifyoutaketoomuchduloxetina,consultyourdoctororpharmacistimmediately.
Incaseofsobredosis,ingestiónaccidental,consulteinmediatamenteasumédicoofarmacéuticoollamealServiciodeInformaciónToxicológica,teléfono:91.562.04.20,indicandoelmedicamentoylacantidadingerida.
Amongthesymptomsproducedbyasobredosis,includesomnolencia,coma,síndromeserotoninérgico,convulsiones,vómitos,yaltafrecuenciacardíaca.
Ifyouaccidentallytakeduloxetina,pleasecontactyourdoctororpharmacistimmediately.
Donottakeanotherdoseofduloxetinauntilyouhavecontactedyourdoctororpharmacistagain.
Ifyoustoptakingduloxetina,donotstoptakingduloxetinawithoutconsultingyourdoctorfirstandfollowtheinstructionsgivenbyyourdoctortogetthebestresultsfromduloxetinaforatleast2weeksbeforestoppingduloxetinacompletelyandconsultyourdoctorbeforestoppingduloxetinacompletelyifyouarenotsurewhattodoorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenotgettingtheresultsyouwantfromduloxetinaorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenotgettingtheresultsyouwantfromduloxetinaorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenotgettingtheresultsyouwantfromduloxetinaorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenotgettingtheresultsyouwantfromduloxetinaorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenotgettingtheresultsyouwantfromduloxetinaorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenotgettingtheresultsyouwantfromduloxetinaorifyouareexperiencinganysideeffectsthatarebotheringyouorifyouarenot Like all medicines, this medicine can cause side effects, although not everyone will experience them. These side effects are usually mild to moderate and often disappear within a few weeks. Very common side effects (may affect more than 1 in 10 patients) Common side effects (may affect up to 1 in 10 patients) Children and adolescents under 18 years of age with depression treated with this medicine experienced a decrease in weight when they started taking this medicine. After 6 months of treatment, the weight increased to similar levels of other children and adolescents of the same age and sex. Uncommon side effects (may affect up to 1 in 100 patients) difficulty controlling movements, e.g., lack of coordination or involuntary movements of the muscles, restless legs syndrome, poor-quality sleep. Rare side effects (may affect up to 1 in 1,000 patients) Frequency not known (cannot be estimated from available data) Reporting of side effects If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine. Keepitoutofthereachofchildren. Donotusethismedicineaftertheexpirydateappearingonthepackaging.Theexpirydateisthelastdayofthemonthindicated. Keepintheoriginalpackaging.Donotstoreatatemperatureabove30°C. Donotthrowthemedicinesintothedrainsorthegarbage.DepositthepackagingandthemedicinesyounolongerneedattheSIGREpointofthepharmacy.Ifindoubt,askyourpharmacisthowtodisposeofthepackagingandthemedicinesyounolongerneed.Thiswillhelptoprotecttheenvironment. -Theactive ingredientis duloxetina. Each capsule contains 30 mg of duloxetina (as hydrochloride). -Theothercomponents are: Caplet content: hypromellose, sugar spheres (cornstarch and sucrose), talc, sucrose, hypromellose phthalate, and triethyl citrate. Caplet coating: gelatin, titanium dioxide (E171), and indigotin. Product appearance and packaging contents Duloxetina Alter 30 mg is a hard-gastrorresistant capsule. The capsules are blue and white. Duloxetina Alter 30 mg is available in packs of 28 capsules. Marketing authorization holder and manufacturer Marketing authorization holder: Alter Laboratories, S.A. Mateo Inurria, 30 28036 Madrid - Spain Manufacturer: Neuraxpharm Pharmaceuticals, S.L. Avda. Barcelona, 69 08970 Sant Joan Despí (Barcelona) - Spain Last review date of this leaflet: The detailed and updated information on thismedicamentis available on the website of the Spanish AgencyofMedicines and Health Products (AEMPS)http://www.aemps.gob.es/.4. Possible Adverse Effects
5. Conservation of Duloxetina Alter
6. Contents of the packaging and additional information
Duloxetina Alter Composition
The average price of Duloxetina alter 30 mg capsulas duras gastrorresistentes efg in July, 2025 is around 13.36 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.